Unknown

Dataset Information

0

Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.


ABSTRACT:

Background

Galectin-3 is an inflammatory marker that is raised in myocardial fibrosis and inflammation. Recent studies have explored its role in predicting atrial fibrillation (AF) outcomes. The aim of this systematic review and meta-analysis is to examine the association between serum concentration of galectin-3 and AF.

Methods

PubMed, EMBASE, and the Cochrane Database were searched. A total of 280 studies were identified, of which 28 studies involving 10 830 patients were included in our meta-analysis.

Results

Galectin-3 is present at higher concentrations in patients with AF than those in sinus rhythm (mean difference [MD] = -0.68 ng/mL, 95% CI: -0.92, -0.44, Z = 5.61, P < .00001). Galectin-3 levels were significantly higher in the persistent AF than in the paroxysmal AF group (MD = -0.94 ng/mL, 95% CI: -1.85, -0.03, Z = 2.04, P = .04). Higher galectin-3 levels were associated with a 45% increase in the odds of developing AF (odds ratio [OR] = 1.45, 95% CI: 1.15, 1.83, Z = 3.11, P = .002) and risk of AF recurrence (hazard ratio [HR] =1.17, 95% CI: 1.06, 1.29, Z = 3.12, P = .002).

Conclusions

Our meta-analysis found that galectin-3 is significantly higher in patients with persistent AF than in those with paroxysmal AF, and can predict both AF development and recurrence after treatment.

SUBMITTER: Gong M 

PROVIDER: S-EPMC7083505 | biostudies-literature | 2020 Mar

REPOSITORIES: biostudies-literature

altmetric image

Publications

Galectin-3 and risk of atrial fibrillation: A systematic review and meta-analysis.

Gong Mengqi M   Cheung Angel A   Wang Qun-Shan QS   Li Guangping G   Goudis Christos A CA   Bazoukis George G   Lip Gregory Y H GYH   Baranchuk Adrian A   Korantzopoulos Panagiotis P   Letsas Konstantinos P KP   Tse Gary G   Liu Tong T  

Journal of clinical laboratory analysis 20200109 3


<h4>Background</h4>Galectin-3 is an inflammatory marker that is raised in myocardial fibrosis and inflammation. Recent studies have explored its role in predicting atrial fibrillation (AF) outcomes. The aim of this systematic review and meta-analysis is to examine the association between serum concentration of galectin-3 and AF.<h4>Methods</h4>PubMed, EMBASE, and the Cochrane Database were searched. A total of 280 studies were identified, of which 28 studies involving 10 830 patients were includ  ...[more]

Similar Datasets

| S-EPMC6382095 | biostudies-literature
| S-EPMC5771018 | biostudies-literature
| S-EPMC9441879 | biostudies-literature
| S-EPMC10715893 | biostudies-literature
| S-EPMC10817980 | biostudies-literature
| S-EPMC7462197 | biostudies-literature
| S-EPMC5498837 | biostudies-other
| S-EPMC5704695 | biostudies-other
| S-EPMC5944514 | biostudies-literature
| S-EPMC8653594 | biostudies-literature